Dr. Rob Leland is a pharmacist who is specialized in Psychiatric in Spokane, Washington. Patients can reach him at 6 E 1st Ave, Spokane or contact him on 509-624-3017. Active license number of Dr. Rob Leland is 20813 for Psychiatric in Washington. Dr. Rob Leland is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Complete Profile:
Dr. Rob Leland speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Rob Leland
Specialization:
Psychiatric
Credentials:
PHARMD
Gender:
Male
Location:
6 E 1st Ave, Spokane, Washington, 99202-1503
Phone:
509-624-3017
Fax:
509-624-4330
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Rob Leland are as mentioned below.
NPI Number:
1497001481
NPI Enumeration Date:
27 Jul, 2012
NPI Last Update On:
27 Jul, 2012
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Rob Leland are as mentioned below.
Specialization
License Number
State
Status
Psychiatric
20813
Washington
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6 E 1st Ave, Spokane, Washington
Zip:
99202-1503
Phone Number:
509-624-3017
Fax Number:
509-624-4330
Patients can reach Dr. Rob Leland at 6 E 1st Ave, Spokane, Washington or can call on phone at 509-624-3017.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.